VASH2 and pachyonychia congenita: Overexpression of VASH2 has also been demonstrated to accelerate malignant transformation and promote gemcitabine resistance in PC.13, 19 Our study has further shown that VASH2 may promote these malignant behaviors, including cell invasion and gemcitabine resistance, in PC cells by stimulating the EMT process in these cells.